To be 17 again--anti-interleukin-17 treatment for psoriasis

Editorial

Ari Waisman. N Engl J Med. 2012.

. 2012 Mar 29;366(13):1251-2.

doi: 10.1056/NEJMe1201071.

Erratum in

No abstract available

Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.
Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JG, Kricorian G, Aras G, Li J, Russell CB, Thompson EH, Baumgartner S. Papp KA, et al. N Engl J Med. 2012 Mar 29;366(13):1181-9. doi: 10.1056/NEJMoa1109017. N Engl J Med. 2012. PMID: 22455412 Clinical Trial.
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.
Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, Braun D, Banerjee S. Leonardi C, et al. N Engl J Med. 2012 Mar 29;366(13):1190-9. doi: 10.1056/NEJMoa1109997. N Engl J Med. 2012. PMID: 22455413 Clinical Trial.